From October 1, 2023 to December 31, 2023, the company has repurchased 1,349,500 shares, representing 2.95% for ¥4,246.78 million. With this, the company has completed the repurchase of 1,664,100 shares, representing 3.63% for ¥5,196.6 million under the buyback announced on May 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,585 JPY | +1.41% | +4.82% | +16.02% |
Mar. 20 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
Mar. 19 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.02% | 1.01B | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.